Mitsubishi UFJ Asset Management Co., Ltd. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 211 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
Mitsubishi UFJ Asset Management Co., Ltd. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$133,880
-38.7%
76,068
+9.3%
0.00%
-100.0%
Q4 2022$218,575
-27.6%
69,610
+12.8%
0.00%0.0%
Q3 2022$302,000
+16.2%
61,704
-1.9%
0.00%0.0%
Q2 2022$260,000
+32.7%
62,874
+86.3%
0.00%0.0%
Q1 2022$196,000
-18.7%
33,743
+9.3%
0.00%0.0%
Q4 2021$241,000
-7.3%
30,861
+6.9%
0.00%0.0%
Q3 2021$260,000
-22.6%
28,881
+2.8%
0.00%
-50.0%
Q2 2021$336,000
-22.0%
28,101
-18.3%
0.00%
-33.3%
Q1 2021$431,000
+20.4%
34,386
+49.8%
0.00%0.0%
Q4 2020$358,000
+125.2%
22,962
+36.2%
0.00%
+200.0%
Q3 2020$159,000
+0.6%
16,863
-4.7%
0.00%
-50.0%
Q2 2020$158,000
+37.4%
17,689
-2.4%
0.00%0.0%
Q1 2020$115,000
-5.0%
18,116
+23.4%
0.00%0.0%
Q4 2019$121,000
-7.6%
14,679
+1.4%
0.00%0.0%
Q3 2019$131,000
+1.6%
14,477
+21.0%
0.00%0.0%
Q2 2019$129,000
-8.5%
11,962
-18.8%
0.00%
-33.3%
Q1 2019$141,000
-8.4%
14,732
+5.5%
0.00%
-25.0%
Q4 2018$154,000
-3.1%
13,964
+49.1%
0.00%
+33.3%
Q3 2018$159,0009,3650.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders